Incyte
INCY
#1110
Rank
A$30.30 B
Marketcap
A$154.34
Share price
2.05%
Change (1 day)
32.88%
Change (1 year)

Incyte (INCY) - Total assets

Total assets on the balance sheet as of September 2025 : A$9.53 Billion

According to Incyte's latest financial reports the company's total assets are A$9.53 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Incyte - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$8.75 B-12.07%
2023-12-31A$9.95 B15.98%
2022-12-31A$8.58 B26.14%
2021-12-31A$6.80 B46.94%
2020-12-31A$4.63 B-5.38%
2019-12-31A$4.89 B30.32%
2018-12-31A$3.75 B27.34%
2017-12-31A$2.94 B29.74%
2016-12-31A$2.27 B64.38%
2015-12-31A$1.38 B42.1%
2014-12-31A$0.97 B37.89%
2013-12-31A$0.70 B121.98%
2012-12-31A$0.31 B-0.9%
2011-12-31A$0.32 B-33.43%
2010-12-31A$0.48 B-39.22%
2009-12-31A$0.79 B140.76%
2008-12-31A$0.32 B4.45%
2007-12-31A$0.31 B-29.7%
2006-12-31A$0.44 B-12.27%
2005-12-31A$0.51 B-23.46%
2004-12-31A$0.66 B30.82%
2003-12-31A$0.51 B-47.9%
2002-12-31A$0.98 B-29.11%
2001-12-31A$1.38 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
A$135.70 B 1,323.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$2.22 B-76.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$173.03 B 1,715.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 3,197.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A$0.85 B-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A$0.73 B-92.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$161.52 B 1,594.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
A$0.15 B-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
A$0.16 B-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA